Empo Health exists to empower diabetic patients and providers to improve care, outcomes and quality of life through innovative in-home health monitoring.

Empo Health addresses diabetic foot ulcers (DFUs) which affect 25% of diabetic patients in their lifetime and lead to significant healthcare costs and amputations in the US. Their FDA-listed Empo® Footprint in-home imaging scale combined with the Empo® Remote Health Link monitoring service enables patients, podiatrists, and payors to detect early signs of ulcers and intervene early when it is least invasive and most cost-effective.

The system captures high-resolution images of patients' feet daily, making monitoring routine and practical for providers and easier for patients.

Founded in 2020 by MIT and Stanford-trained engineers, headquartered in San Bruno, California.